Home / Business and Economy / AG1 Eyes $2B Sale Amidst Nutrition Boom
AG1 Eyes $2B Sale Amidst Nutrition Boom
11 Apr
Summary
- AG1 is exploring a company sale, potentially valued over $2 billion.
- Celebrities like Hugh Jackman are among AG1's investors.
- The company's revenue grew significantly from $150 million to $600 million.
Nutritional supplement brand AG1 is actively considering its future, with options on the table including a complete sale of the company or the divestment of a minority stake. Sources indicate that any potential transaction could value the business, previously recognized as Athletic Greens, at more than $2 billion, inclusive of debt. The company has attracted high-profile investors such as Hugh Jackman, Lewis Hamilton, and Steve Aoki. AG1 is reportedly working with investment bank Goldman Sachs to navigate these strategic explorations. This move comes as the vitamins and nutrition sector experiences a surge in merger and acquisition activity. Consumers are increasingly focused on health and longevity, while users of GLP-1 weight loss drugs are seeking nutritional support. AG1, known for its comprehensive green powder supplement, has seen impressive financial growth, with revenue escalating from roughly $150 million in 2022 to approximately $600 million in 2024. Founded in 2010 by Chris Ashenden, the company offers its products in powder and liquid drop forms, available both online and through major retailers like Costco and Walmart.
